
    
      Randomised two arm pragmatic clinical study to be conducted at multiple sites in US and
      Canada. The trial will recruit hematuria subjects, presenting to qualified sites (academic,
      community), who are being evaluated for urothelial carcinoma (UC). Up to 100 consecutive
      eligible subjects will be recruited per site.
    
  